Rein Therapeutics Inc. – Filings and Transcripts

NASDAQ: RNTX
Share price (6/2/26): $1.03
Market cap (6/2/26): $88.1 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025 – amended

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Initial registration of new securities

Draft registration statement

Initial registration of new securities

Prospectus supplement for primary offering

Ownership Filter

Von Rickenbach Josef H

Windsor James Brian

BIOS Fund I, LP

Lynwood Capital Management Inc.

Funicular Funds, LP

News Filter

Announces Pricing of $50 Million Underwritten Public Offering of Common Stock

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Change in Directors, Officers or Compensation

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Termination of Material Definitive Agreement

Proxies Filter

Preliminary proxy

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness